PHTS Telemedizin Provides Telemedicine Solutions

SHL Telemedicine LtdSHL Telemedicine Ltd. (SWX:SHLTN), a leading provider and developer of advanced personal telemedicine solutions, is pleased to announce that its wholly owned German subsidiary PHTS Telemedizin is part of an integrated care services contract in the state of Schleswig-Holstein whereby family doctors, physicians and hospitals in Schleswig-Holstein will refer patients of public health insurance companies IKK Nord and IKK-Direkt suffering from chronic heart illnesses to PHTS Telemedizin for the reception of telemedicine services.

PHTS Telemedizin (www.phts.de), through its monitoring centre based in Dusseldorf, will provide these patients suffering from chronic heart illnesses improved care around the clock.

Some of the PHTS Telemedizin (www.phts.de) partners in this integrated care solution are: IKK Nord, IKK-Direkt, Deutscher Hausärzteverband, Landesverband Schleswig-Holstein, Ärztegenossenschaft Schleswig-Holstein eG, 4K-Verbund der Kliniken Medizinisches Zentrum Klinikum Itzehoe, Westküstenkliniken Heide und Brunsbüttel gGmbH, FEK Friedrich-Ebert-Krankenhaus Neumünster GmbH, Universitätsklinikum Schleswig- Holstein Kiel and Universitätsklinikum Schleswig-Holstein Lubeck.

Eyal Lewin, Managing Director of PHTS Telemedizin (www.phts.de), comments: "Schleswig-Holstein's vast territory is well suited for the application of cardiac telemedicine solutions and I am confident in our ability to improve the quality of care for the chronically ill."

Erez Alroy, Co-CEO of SHL Telemedicine, adds: "We are very pleased with the development in the German market. The cooperation with the health community in Schleswig-Holstein emphasizes PHTS Telemedizin's leading position in the German telemedicine market and its continuing growth and progress. The goal of this contract is to improve the quality of care and quality of life for chronically ill heart patients and at the same time achieve better cost-efficiency."

About SHL TeleMedicine
SHL TeleMedicine Ltd. is a leading provider and developer of advanced personal telemedicine solutions to individuals and to the healthcare community. As a provider of remote health services in cardiology and in other medical areas, SHL maintains business operations in the US, Europe and Israel. SHL is listed on the SWX Swiss Exchange, symbol SHLTN. For more information see www.shl-telemedicine.com.

Most Popular Now

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

RSNA AI Challenge Models can Independent…

Algorithms submitted for an AI Challenge hosted by the Radiological Society of North America (RSNA) have shown excellent performance for detecting breast cancers on mammography images, increasing screening sensitivity while...

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Routine AI Assistance may Lead to Loss o…

The introduction of artificial intelligence (AI) to assist colonoscopies is linked to a reduction in the ability of endoscopists (health professionals who perform colonoscopies) to detect precancerous growths (adenomas) in...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...